How do I get Skyrizi through my insurance?
Tell us what Skyrizi is treating and how you’re insured. We connect you to the benefit path and the current official policy that matters — then show financial-assistance options.
Choose the diagnosis.
This matters because the route — and therefore the insurance benefit — changes by indication.
Skyrizi can cross from medical benefit to pharmacy benefit.
Weeks 0, 4 and 8
Crohn’s and UC start with IV infusions. Those provider-administered doses are the part most likely to be evaluated under a medical-benefit policy. The IV drug code is J2327.
Week 12 and after
Maintenance changes to subcutaneous Skyrizi. Many commercial plans move this portion to specialty pharmacy / prescription-benefit rules. That can mean a second authorization pathway.
Find help with your out-of-pocket costs.
Use the official support program below to check savings, patient-assistance, or access options that may apply to you.
Open official Skyrizi support →What people actually Google.
How do I get Skyrizi through my insurance?
Start with the diagnosis, then determine whether the prescribed dose is IV or subcutaneous. For Crohn’s disease and ulcerative colitis, the first three doses are IV, so the insurer’s medical-benefit drug policy is the key starting point. Check that policy’s prior-authorization criteria, then move to financial assistance.
Does having Crohn’s disease mean my insurance automatically covers Skyrizi?
No. Crohn’s disease is an FDA-approved indication, but an insurer can still require medical-necessity criteria, previous treatment, prior authorization, a specialist, specific dosing or site-of-care rules. Your individual benefit plan controls the final decision.
Will Medicare Part B pay for Skyrizi?
Part B covers most injectable and infused drugs administered by licensed medical providers when Medicare requirements are met. For Crohn’s and ulcerative colitis, Skyrizi’s IV induction is the Part B-relevant portion. The claim still has to meet medical-necessity, coding and local contractor requirements.
Why does MedicineCostHelp link to insurer policies instead of copying them?
The official insurer page is the source that can change. MedicineCostHelp’s job is to connect the drug, diagnosis and insurance to the correct source, explain the coverage path in plain language where appropriate, and show when a source’s terms call for link-only navigation.
The medicine may be only part of the problem.
Use the playbook that matches what is blocking treatment, then verify the current rule with the insurer, program or treatment site.
Approval is pending, expired or unclear.
Find the rule, status and next authorization step.
DENIEDFind the reason before appealing.
Separate medical-necessity, benefit, product and claim problems.
PREFERRED PRODUCTThe plan wants a different brand or biosimilar.
Understand product preference without making a treatment recommendation.
SITE OF CAREThe medicine may be covered, but the location is not.
Check network, site and authorization requirements.
COST TOO HIGHSeparate coverage from financial assistance.
Understand manufacturer support versus independent foundations.
CLAIM PROBLEMAuthorization was approved, but billing still failed.
Compare the approval with the product, site and claim that were billed.
Important
MedicineCostHelp is an educational navigation tool, not an insurer and not a coverage determination. Published medical policies are only part of the answer. A member’s benefit plan, employer plan terms, state/federal requirements, prior-authorization review, medical necessity, site of care and current insurer rules can change the outcome. Sources were reviewed 2026-08-20. Verify the current official source before acting.